文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

双氢青蒿素-哌喹间歇性预防治疗在HIV感染孕妇中预防疟疾的效果

Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.
PubMed 文献 · J Infect Dis · 2017-01-01

在乌干达已实施室内滞留喷洒的地区,纳入200例HIV感染孕妇,随机比较每日复方磺胺甲噁唑联合每月双氢青蒿素-哌喹与单用复方磺胺甲噁唑。194例评估主要结局,组织病理学检测胎盘疟疾感染风险两组无统计学显著差异(6.1% vs 3.1%;RR 1.96;

要点

  • 在室内滞留喷洒地区,加用每月DP未降低胎盘疟疾感染风险。
  • 两组组织病理学胎盘疟疾感染率分别为6.1%和3.1%,差异无统计学意义。
  • 疟疾发病率、寄生虫携带率及不良出生结局等次要结局均无差异。

核心结论

  • 在已实施室内滞留喷洒的乌干达地区,HIV感染孕妇在每日复方磺胺甲噁唑基础上加用每月双氢青蒿素-哌喹未能降低胎盘或母体疟疾风险,也未改善出生结局。

研究设计与样本

  • 双盲、随机、安慰剂对照试验,在乌干达近期已实施室内滞留喷洒的地区纳入HIV感染孕妇。
  • 受试者在孕12至28周入组并获发药浸蚊帐,随机接受每日复方磺胺甲噁唑联合每月双氢青蒿素-哌喹或每日复方磺胺甲噁唑单药。
  • 共200例入组并随访至分娩,其中194例完成主要结局评估。

主要发现

  • 疟疾发病率、寄生虫携带率及不良出生结局等次要结局两组间均无差异。

临床怎么用

  • 在已实施室内滞留喷洒的地区,HIV感染孕妇不应常规在每日复方磺胺甲噁唑基础上加用每月双氢青蒿素-哌喹以预防疟疾。
  • 每日复方磺胺甲噁唑和药浸蚊帐仍是HIV感染孕妇疟疾预防的主要干预措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Daily trimethoprim-sulfamethoxazole (TMP-SMX) and insecticide-treated nets remain the main interventions for prevention of malaria in human immunodeficiency virus (HIV)-infected pregnant women in Africa. However, antifolate and pyrethroid resistance threaten the effectiveness of these interventions, and new ones are needed. METHODS: We conducted a double-blinded, randomized, placebo-controlled trial comparing daily TMP-SMX plus monthly dihydroartemisinin-piperaquine (DP) to daily TMP-SMX alone in HIV-infected pregnant women in an area of Uganda where indoor residual spraying of insecticide had recently been implemented. Participants were enrolled between gestation weeks 12 and 28 and given an insecticide-treated net. The primary outcome was detection of active or past placental malarial infection by histopathologic analysis. Secondary outcomes included incidence of malaria, parasite prevalence, and adverse birth outcomes. RESULT: All 200 women enrolled were followed through delivery, and the primary outcome was assessed in 194. There was no statistically significant difference in the risk of histopathologically detected placental malarial infection between the daily TMP-SMX plus DP arm and the daily TMP-SMX alone arm (6.1% vs. 3.1%; relative risk, 1.96; 95% confidence interval, .50-7.61; P = .50). Similarly, there were no differences in secondary outcomes. CONCLUSIONS: Among HIV-infected pregnant women in the setting of indoor residual spraying of insecticide, adding monthly DP to daily TMP-SMX did not reduce the risk of placental or maternal malaria or improve birth outcomes. CLINICAL TRIALS REGISTRATION: NCT02282293.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Natureeba P, Kakuru A, Muhindo M, et al. Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women. J Infect Dis. 2017. PMID: 28329368. doi:10.1093/infdis/jix110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。